Costo-Efficacia Di Cabozantinib Nel Trattamento Di Seconda Linea Del Tumore a Cellule Renali Metastatico (mRCC) in Italia

Global and Regional Health Technology Assessment - Italy
doi 10.1177/2284240318790734
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Aboutscience Srl


Related search